ATE466857T1 - Neue piperidin-antibiotika - Google Patents

Neue piperidin-antibiotika

Info

Publication number
ATE466857T1
ATE466857T1 AT05786765T AT05786765T ATE466857T1 AT E466857 T1 ATE466857 T1 AT E466857T1 AT 05786765 T AT05786765 T AT 05786765T AT 05786765 T AT05786765 T AT 05786765T AT E466857 T1 ATE466857 T1 AT E466857T1
Authority
AT
Austria
Prior art keywords
antibiotics
new piperidine
piperidine
new
piperidine antibiotics
Prior art date
Application number
AT05786765T
Other languages
German (de)
English (en)
Inventor
Jean-Philippe Surivet
Christian Hubschwerlen
Acklin Cornelia Zumbrunn
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35453391&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE466857(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE466857T1 publication Critical patent/ATE466857T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT05786765T 2004-10-05 2005-10-03 Neue piperidin-antibiotika ATE466857T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2004011087 2004-10-05
PCT/IB2005/053238 WO2006038172A1 (en) 2004-10-05 2005-10-03 New piperidine antibiotics

Publications (1)

Publication Number Publication Date
ATE466857T1 true ATE466857T1 (de) 2010-05-15

Family

ID=35453391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05786765T ATE466857T1 (de) 2004-10-05 2005-10-03 Neue piperidin-antibiotika

Country Status (10)

Country Link
US (1) US20070173532A1 (es)
JP (1) JP2008515796A (es)
CN (1) CN101039935B (es)
AR (1) AR051051A1 (es)
AT (1) ATE466857T1 (es)
CA (1) CA2581057A1 (es)
DE (1) DE602005021133D1 (es)
ES (1) ES2343127T3 (es)
TW (1) TW200616959A (es)
WO (1) WO2006038172A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2330670T3 (es) * 2005-05-25 2009-12-14 Actelion Pharmaceuticals Ltd. Nuevos derivados antibioticos.
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
BRPI0617376A2 (pt) * 2005-10-13 2011-07-26 Morphochem Ag derivados de 5-quinolina tendo uma atividade antibacteriana
DE602007009205D1 (de) 2006-04-06 2010-10-28 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TW200819457A (en) * 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
MY149347A (en) * 2007-04-20 2013-08-30 Glaxo Group Ltd Tricyclic nitrogen containing compounds as antibacterial agents
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
WO2010081874A1 (en) 2009-01-15 2010-07-22 Glaxo Group Limited Naphthyridin-2 (1 h)-one compounds useful as antibacterials
US9085557B2 (en) 2010-05-06 2015-07-21 Council Of Scientific And Industrial Research Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof
BR112017003705B1 (pt) 2014-08-22 2022-07-12 Glaxosmithkline Intellectual Property Development Limited Compostos contendo nitrogênio tricíclicos para o tratamento de infecção por neisseria gonorrhoea
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
NZ763766A (en) 2017-03-20 2023-07-28 Novo Nordisk Healthcare Ag Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
BR112021005188A2 (pt) 2018-09-19 2021-06-08 Forma Therapeutics, Inc. tratamento de anemia falciforme com um composto de ativação de piruvato cinase r
EP3852791B1 (en) 2018-09-19 2024-07-03 Novo Nordisk Health Care AG Activating pyruvate kinase r

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
WO2000043383A1 (en) * 1999-01-20 2000-07-27 Smithkline Beecham P.L.C. Piperidinylquinolines as protein tyrosine kinase inhibitors
FR2798656B1 (fr) * 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
GB0112836D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
TW200406413A (en) * 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
WO2004035569A2 (de) * 2002-10-10 2004-04-29 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
DE10247233A1 (de) * 2002-10-10 2004-06-17 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
US6982334B2 (en) * 2002-12-20 2006-01-03 Aventis Pharma S.A. Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität

Also Published As

Publication number Publication date
CN101039935A (zh) 2007-09-19
WO2006038172A1 (en) 2006-04-13
TW200616959A (en) 2006-06-01
US20070173532A1 (en) 2007-07-26
CA2581057A1 (en) 2006-04-13
CN101039935B (zh) 2011-04-20
DE602005021133D1 (de) 2010-06-17
AR051051A1 (es) 2006-12-13
JP2008515796A (ja) 2008-05-15
ES2343127T3 (es) 2010-07-23

Similar Documents

Publication Publication Date Title
ATE466857T1 (de) Neue piperidin-antibiotika
ATE414693T1 (de) Neuartige cis-imidazoline
ATE387440T1 (de) Neue 4-benzylidenpiperidinderivate
DE602006016573D1 (de) Substituierte piperidine
DE602005023145D1 (de) Neue androgene
ATE425167T1 (de) Neue pyridothienopyrimidinderivate
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
FI20045062A0 (fi) Taajuusmuuttajan konfigurointi
SE0400898L (sv) Flytkonstruktion
AT500198B8 (de) Ladewagen
NO20042479L (no) Innlopsinnretning
AT500249A3 (de) Scheibenegge
FR2871686B1 (fr) Composition anti-decoloration
DE602005016400D1 (de) Stellgliedanordnung
AT501079B1 (de) Türe
AT7802U3 (de) Parfum-zerstäuber
FI6354U1 (fi) Ohjauslaite
SE0400205D0 (sv) Composition
ITRO20040014A1 (it) Pannello legnocuoio
UA10544S (uk) Двері
UA8988S (uk) Двері
UA11052S (uk) Двері
UA11053S (uk) Двері
UA11210S (uk) Двері
UA11209S (uk) Двері

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties